4 completed, 1 withdrawn. 4 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Inreda Diabetic B.V.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System Dasiglucagon, GlucaGen - Diabetes Mellitus, Type 1 | Phase 2 | Withdrawn | Inreda Diabetic B.V. | 2023-12-29 | 2024-01-03 | |
| Dual Hormone Closed Loop in Type 1 Diabetes dual hormone fully closed loop (DHFCL) - Diabetes Mellitus, Type 1, Diabetes type1 | Not applicable | Completed | UMC Utrecht | 243 | 2023-10-03 | 2026-01-21 |
| Portable Artificial Pancreas Applied for Youth and Adolescents Bi-hormonal closed-loop control, Open-loop control - Diabetes Mellitus, Type 1 | Not applicable | Completed | Inreda Diabetic B.V. | 20 | 2022-10-28 | 2023-08-14 |
| Ultrarapid Insulin Administered by a Bihormonal Closed Loop System in Patients With Type 1 Diabetes Insulin Lispro Cartridge [Lyumjev], Insulin Lispro Cartridge - Type 1 Diabetes | Not applicable | Completed | Inreda Diabetic B.V. | 12 | 2022-10-19 | 2026-02-17 |
| Algorithm to Control Postprandial, Post Exercise and Night Glucose Excursions in a Portable Closed Loop Format, Insulin pump therapy (with or without glucose sensor), Artificial pancreas (Inreda Diabetic) - Diabetes Mellitus, Type 1 | Not applicable | Completed | J.H. DeVries | 36 | 2019-03-10 | 2019-10-22 |
Diabetes Mellitus, Type 1 (5) · Diabetes Mellitus (1)
Pancreas, Artificial (2) · Glucagon-Like Peptide 1 (1) · Insulin Lispro (1) · dasiglucagon (1)
Netherlands (5)
A. van Bon, MD, PhD (1) · Arianne Bon, MD, PhD (1) · G Laverman, MD (1) · J.H. DeVries, MD PhD (1)